In vitro ATR kinase assay

JZ Jingwen Zhang
AD Austin M. Dulak
MH Maureen M. Hattersley
BW Brandon S. Willis
JN Jenni Nikkilä
AW Anderson Wang
AL Alan Lau
CR Corinne Reimer
MZ Michael Zinda
SF Stephen E. Fawell
GM Gordon B. Mills
HC Huawei Chen
request Request a Protocol
ask Ask a question
Favorite

In vitro ATR kinase assay was perforem by Eurofins Pharma Discovery Services (Dundee, UK). Briefly, ATR/ATRIP (human) is incubated in assay buffer containing 50 nM GST-cMyc-p53 and various concentrations of compounds. The reaction is initiated by the addition of the Mg/ATP (10 μM) mix. After incubation for 30 minutes at room temperature, the reaction is stopped by the addition of stop solution containing EDTA. Finally, detection buffer is added, which contains d2-labelled anti-GST monoclonal antibody, and a Europium-labelled anti-phospho Ser15 antibody against phosphorylated p53. The plate is then read in time-resolved fluorescence mode and the homogeneous time-resolved fluorescence (HTRF) signal is determined according to the formula HTRF = 10000 × (Em665nm/Em620nm). Results shown represent average of three independent experiments.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A